Advanced Search

 

Study ID Status Title Patient Level Data
115306 Relinquished A Phase III, randomized, double-blinded study comparing the combination of the BRAF inhibitor, dabrafenib and the MEK inhibitor, trametinib to dabrafenib and placebo as first-line therapy in subjects with unresectable (Stage IIIC) or metastatic (Stage IV) BRAF V600E/K mutation-positive cutaneous melanoma
115312 Terminated A post-marketing surveillance study of AvamysTM (Fluticasone furoate) in the treatment of Filipino patients with Allergic Rhinitis (AR)
115317 Completed A non-inferiority study of Glimepiride/Atorvastatin FDC compared to glimepiride and atorvastatin as separate tablets in Type II diabetic subjects. Study Listed on ClinicalStudyDataRequest.com
115321 Completed A randomized, double blind, placebo controlled, incomplete block, crossover, dose ranging study to evaluate the dose response of GSK573719 administered once or twice daily over 7 days in patients with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
115324 Completed Special Drug Use Investigation for LAMICTAL Bipolar
115325 Completed A Randomized, Open-Label, Crossover Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ Administered Concurrently in Healthy Adult Subjects
115332 Completed A Single-arm, Open Label Study Evaluating the Impact on Lifestyle of a New Thermo Stable Formulation of FLOLAN® in Subjects with Pulmonary Arterial Hypertension (PAH). (FLOLAN® is a registered trademark of the GlaxoSmithKline group of companies.)
115345 Completed An efficacy study of GSK Biologicals’ quadrivalent influenza vaccine GSK2321138A (FLU D-QIV) when administered in children
115354 Completed PGx411:Evaluation of the Genetic Contribution (efficacy) to the Steroid Response in studies FFA109684, FFA109685 and FFA109687
115354_1 Completed PGx411:Evaluation of the Genetic Contribution (efficacy) to the Steroid Response in studies FFA109684, FFA109685 and FFA109687
115356 Completed To evaluate incidence of acute otitis media in children aged less than 6 years in five East European countries
115358 Completed A 6-month safety and benefit study of inhaled fluticasone propionate/ salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatric subjects 4-11 years old with persistent asthma Study Listed on ClinicalStudyDataRequest.com
115359 Completed SAS115359, a Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma Study Listed on ClinicalStudyDataRequest.com
115360 Completed A Single and Repeat Dose pharmacokinetics/ pharmacodynamics (PK/PD) Study to Characterise theBiomarker Response in Healthy Subjects Treated with the AntiinflammatoryMacrolide Azithromycin
115361 Completed A 52-week, Multi-centre, Open-label Study to Evaluate the Safety and Tolerability of GSK573719 125 mcg once-daily via novel Dry Powder Inhaler (nDPI) in Japanese Subjects with Chronic Obstructive Pulmonary Disease. Study Listed on ClinicalStudyDataRequest.com
115362 Completed A 52-week, Multi-centre, Open-label Study to Evaluate the Safety and Tolerability of GSK573719 125 mcg once-daily in combination with GW642444 25 mcg once-daily via novel Dry Powder Inhaler (nDPI) in Japanese Subjects with Chronic Obstructive Pulmonary Disease. Study Listed on ClinicalStudyDataRequest.com
115373 Completed Safety and immunogenicity study of GSK Biologicals’ pneumococcal vaccine 2830930A when administered as a single dose in healthy toddlers aged 12-23 months
115374 Completed Assessment of safety of GlaxoSmithKline (GSK) Biologicals’ combined reduced antigen content diphtheria-tetanus toxoids and acellular pertussis vaccine (dTPa), Boostrix when administered according to the approved Prescribing Information in Korea
115375 Completed Antibody persistence in children previously vaccinated with three doses of Infanrix hexa™ or Infanrix-IPV/Hib™ Study Listed on ClinicalStudyDataRequest.com
115376 Completed A multi-center, uncontrolled, open-label, evaluation of Lamotrigine monotherapy in newly diagnosed epilepsy or recurrent epilepsy (currently untreated) Study Listed on ClinicalStudyDataRequest.com
115377 Completed A multi-center, uncontrolled, open-label, evaluation of Lamotrigine monotherapy on newly diagnosed typical absence seizures in children and adolescents Study Listed on ClinicalStudyDataRequest.com
115380 Completed A Randomized, Open Label, 3 Crossover, Balanced Incomplete Block Study To Evaluate The Pharmacokinetics Of Umeclidinium Bromide and Vilanterol Trifenatate as Monotherapies and Concurrently in Healthy Chinese Subjects. Study Listed on ClinicalStudyDataRequest.com
115381 Completed An Open-Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (dolutegravir, DTG) in Healthy Japanese Subjects
115385 Completed A Phase I, Randomized, Single-Blind, Placebo-Controlled, Dose-Escalation (Part 1), fixed Sequence and Open-Label (Part 2), Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
115387 Completed A single-centre, escalating dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of a slow intravenous infusion of GW328267X in healthy volunteers Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.